Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03276533
Other study ID # xuzhang2013
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2017
Est. completion date August 10, 2020

Study information

Verified date March 2022
Source Anqing Municipal Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Objective: The present study was to evaluate the effects of dexmedetomidine alone, lidocaine alone and their combined infusion on postoperative inflammation cytokines after Laparoscopic hysterectomy. Methods: Investigators enrolled 160 women with American Society of Anesthesiologists (ASA) physical status I and II, aged 40-65 years, and scheduled for elective laparoscopic hysterectomy with general anesthesia from October 2017 to August 2018. The participants were randomly assigned into four groups(n=40 each group): group CON received normal saline infusion, group LIDO received lidocaine infusion (1.5 mg/kg loading, 1.5 mg/kg/h infusion), group DEX received dexmedetomidine infusion (0.5 µg/kg loading, 0.4 µg/kg/h infusion) and group LIDO+DEX received lidocaine (1.5 mg/kg loading, 1.5 mg/kg/h infusion) and dexmedetomidine infusions (0.5 µg/kg loading, 0.4 µg/kg/h infusion). The four groups received an IV bolus infusion of normal saline, lidocaine, dexmedetomidine and lidocaine combined with dexmedetomidine respectively, over 10 minutes before induction of anesthesia, followed by a continuous IV infusion of normal saline, lidocaine, dexmedetomidine and lidocaine combined with dexmedetomidine until abdominal wound closure, respectively. Interleukin-6 and tumor necrosis factor-α levels in serum were measured at different time points: before administration of drugs (T1), the end of surgery (T2), postoperative 2 hour (T3) and postoperative 24 hour (T4).


Recruitment information / eligibility

Status Completed
Enrollment 160
Est. completion date August 10, 2020
Est. primary completion date August 6, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 40 Years to 65 Years
Eligibility Inclusion Criteria: - American Society of Anesthesiologists (ASA) physical status I and II - weighted 50 kg-65 kg - aged 40-65 yr - elective laparoscopic hysterectomy with general anesthesia Exclusion Criteria: - a history of allergy to local anesthetics - severe respiratory, renal or hepatic disease - preoperative opioids medication - psychiatric medical history - Patients with severe hypotension [mean arterial pressure (MAP<60 mmHg)] or bradycardia [heart rate (HR) <40 beats per minute (bpm)], arrhythmia, or urticaria due to lidocaine and dexmedetomidine infusion during the surgery

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Saline
Participants in the group CON were received normal saline infusion until 30 min before the end of the operation.Interleukin-6 and tumor necrosis factor-a levels in serum were measured at different time points: before administration of drugs (T1), at the end of the operation (T2), postoperative 2 hour (T3) and postoperative 24 hour (T4)
Lidocaine
Participants in the group LIDO received lidocaine infusion (1.5 mg/kg loading, 1.5 mg/kg/h infusion)until 30 min before the end of the operation.Interleukin-6 and tumor necrosis factor-a levels in serum were measured at different time points: before administration of drugs (T1), at the end of the operation (T2), postoperative 2 hour (T3) and postoperative 24 hour (T4)
Dexmedetomidine
Participants in the group DEX received dexmedetomidine infusion (0.5 µg/kg loading, 0.4 µg/kg/h infusion) until 30 min before the end of the operation. Interleukin-6 and tumor necrosis factor-a levels in serum were measured at different time points: before administration of drugs (T1), at the end of the operation (T2), postoperative 2 hour (T3) and postoperative 24 hour (T4)
Lidocaine plus Dexmedetomidine
Participants in the group LIDO+DEX were received lidocaine (1.5 mg/kg loading, 1.5 mg/kg/h infusion) and dexmedetomidine infusion (0.5 µg/kg loading, 0.4 µg/kg/h infusion) until 30 min before the end of the operation, respectively. Interleukin-6 and tumor necrosis factor-a levels in serum were measured at different time points: before administration of drugs (T1), at the end of the operation (T2), postoperative 2 hour (T3) and postoperative 24 hour (T4)

Locations

Country Name City State
China Department of Anqing Hospital Anesthesiology Anqing Anhui

Sponsors (2)

Lead Sponsor Collaborator
Anqing Municipal Hospital The First Affiliated Hospital of Anhui Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Interleukin-6 Interleukin-6 level in serum was measured at the before administration of drugs (T1), Interleukin-6 level in serum was measured at the end of the operation (T2); Interleukin-6 level in serum was measured at the postoperative 2 hour (T3); Interleukin-6 level in serum was measured at the postoperative 24 hour (T4) postoperative 24 hours
Primary Tumor necrosis factor-a Tumor necrosis factor-a level in serum was measured at the before administration of drugs (T1); Tumor necrosis factor-a level in serum was measured at the end of the operation (T2); Tumor necrosis factor-a level in serum was measured at the postoperative 2 hour (T3); Tumor necrosis factor-a level in serum was measured at the postoperative 24 hour (T4) postoperative 24 hours
Primary Interleukin-1 Interleukin-1 level in serum was measured at the before administration of drugs (T1); Interleukin-1 level in serum was measured at the end of the operation (T2); Interleukin-1 level in serum was measured at the postoperative 2 hour (T3); Interleukin-1 level in serum was measured at the postoperative 24 hour (T4) postoperative 24 hours
See also
  Status Clinical Trial Phase
Recruiting NCT05358535 - Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial) Phase 3
Recruiting NCT03839784 - Building a Platform for Precision Anesthesia in the Geriatric Surgical Patient
Completed NCT04399226 - Dexmedetomidine-Propofol and Ketamine-Propofol During Upper Gastrointestinal System Sedation
Recruiting NCT05024838 - Prediction of Block Height of Spinal Anesthesia
Completed NCT05383417 - No Post Intubation Laryngeal Symptoms N/A
Enrolling by invitation NCT02104908 - Study of Nerve Block Anesthesia for Surgery of Hip Fracture in the Elderly Phase 4
Recruiting NCT01329874 - Anesthetic Efficacy of Gow-Gates Versus Conventional Inferior Alveolar Nerve Block Techniques N/A
Completed NCT01651988 - Efficacy of Ketamine-Propofol for Short Surgical Procedures Phase 4
Recruiting NCT01898897 - Influence of Anesthesia Technique on Postoperative Evolution After Urogenital Surgical Interventions N/A
Recruiting NCT04435834 - Individual Cerebral Hemodynamic Oxygenation Relationships Phase 4
Not yet recruiting NCT02143362 - Dexmedetomidine Combined With the Closed Loop of Target Controlled Infusion of Propofol for Anesthesia With Intraoperative Wake up Phase 4
Completed NCT02136641 - Study of Comparison of the Effectiveness of Three Diagrams for Sedation in Spinal Anesthesia Phase 4
Completed NCT02429323 - Endotracheal Intubation With Sevoflurane in Surgical Pediatric Patients N/A
Not yet recruiting NCT05869578 - Registry of Anesthesia and Perioperative Medicine
Completed NCT03134677 - The Effects of Different Anesthetic Techniques on QT, Corrected QT (QTc), and P Wave Dispersions in Cesarean Section Phase 4
Enrolling by invitation NCT02355093 - Adductor Canal Block Versus Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction Arthroscopically Phase 4
Completed NCT03161275 - Measurement of the Cerebral Saturation for Assessment of Safety of Epidural Anaesthesia During Abdominal Surgery N/A
Recruiting NCT03237429 - The Relationship Between BCM, Arterial Stiffness and Hemodynamic Instability During Induction of General Anesthesia
Active, not recruiting NCT05610007 - Comparison of Hyperbaric Prilocaine 2% 50 Mg and Hyperbaric Bupivacaine 0.5% 12.5 Mg Against Spinal Anesthesia Recovery Time in Cystoscopy Procedure Phase 4
Completed NCT04906772 - Dexmedetomidine-ketamine Versus Propofol-ketamine for Sedation During Endoscopy in Hepatic Patients Phase 4